← Open Payments lookup

ELSA CORREA-DELEONARDO: Open Payments

NPI 1396222907 · REISTERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,612 in 103 payments from 12 companies in 2025. Trend: 2023 $1,777 · 2024 $2,390 · 2025 $2,612

Food & beverage: $2,612
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$387
Teva Pharmaceuticals USA, Inc.12$385
Alkermes, Inc.22$364
E.R. Squibb & Sons, L.L.C.8$331
Axsome Therapeutics, Inc.8$275
Neurocrine BioSciences, Inc.3$244
Otsuka America Pharmaceutical, Inc.14$172
ABBVIE INC.14$157
Lundbeck LLC5$112
Vanda Pharmaceuticals Inc.3$91

Products named: CAPLYTA, ARISTADA, UZEDY, COBENFY, Auvelity, INGREZZA, REXULTI, VRAYLAR.

Industry payments across MD — which companies pay providers there.